Recap: Allogene Therapeutics Q4 Earnings

Allogene Therapeutics ALLO reported its Q4 earnings results on Thursday, March 14, 2024 at 04:02 PM.

Here's what investors need to know about the announcement.

Earnings

Allogene Therapeutics missed estimated earnings by -13.0%, reporting an EPS of $-0.51 versus an estimate of $-0.45.

Revenue was down $26 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.15 which was followed by a 18.0% increase in the share price the next day.

Here's a look at Allogene Therapeutics's past performance:

To track all earnings releases for Allogene Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.